Pharmala Biotech Holdings (XCNQ:MDMA) Effective Interest Rate on Debt % : 0.00% (As of Feb. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Pharmala Biotech Holdings Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Pharmala Biotech Holdings's annualized positive value of Interest Expense for the quarter that ended in Feb. 2024 was C$0.00 Mil. Pharmala Biotech Holdings's average total debt for the quarter that ended in Feb. 2024 was C$0.00 Mil. Therefore, Pharmala Biotech Holdings's annualized Effective Interest Rate on Debt % for the quarter that ended in Feb. 2024 was N/A%.

Pharmala Biotech Holdings Effective Interest Rate on Debt % Historical Data

The historical data trend for Pharmala Biotech Holdings's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmala Biotech Holdings Effective Interest Rate on Debt % Chart

Pharmala Biotech Holdings Annual Data

Trend

Aug21

Aug22

Aug23

Effective Interest Rate on Debt %

Pharmala Biotech Holdings Quarterly Data
	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Effective Interest Rate on Debt %	Get a 7-Day Free Trial							-	-	-	-	-

Competitive Comparison of Pharmala Biotech Holdings's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Pharmala Biotech Holdings's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmala Biotech Holdings's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmala Biotech Holdings's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Pharmala Biotech Holdings's Effective Interest Rate on Debt % falls into.

Pharmala Biotech Holdings Effective Interest Rate on Debt % Calculation

Pharmala Biotech Holdings's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Aug. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Aug. 2022 )	+	Total Debt (A: Aug. 2023 ))	/ count )
=	-1 * 0	/	( (0	+	0.254)	/ 1 )
=	-1 * 0	/	0.254
=	0.00 %

where

	Total Debt (A: Aug. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	0
=	0

	Total Debt (A: Aug. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	0.254
=	0.254

Pharmala Biotech Holdings's annualized Effective Interest Rate on Debt % for the quarter that ended in Feb. 2024 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Nov. 2023 )	+	Total Debt (Q: Feb. 2024 ))	/ count )
=	-1 * 0	/	( (0	+	0)	/ 1 )
=	-1 * 0	/	0
=	N/A %

where

	Total Debt (Q: Nov. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	0
=	0

	Total Debt (Q: Feb. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	0
=	0

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Feb. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Pharmala Biotech Holdings (XCNQ:MDMA) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Pharmala Biotech Holdings Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Pharmala Biotech Holdings's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmala Biotech Holdings (XCNQ:MDMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmala Biotech Holdings Inc (XCNQ:MDMA) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

PMBHF:USA

Address

82 Richmond Street East, Toranto, ON, CAN, M5C 1P1

Website

https://www.pharmala.ca

Pharmala Biotech Holdings Inc is focused on manufacturing and sales of MDMA and MDXX Active Pharmaceutical Ingredients (API) for use in clinical research. PharmAla's drug API is manufactured and encapsulated under GMP conditions. The Company generates revenue from the sale of tablets and raw MDMA and MDXX compounds/formulations.

Pharmala Biotech Holdings (XCNQ:MDMA) Headlines

No Headlines